These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The A3 adenosine receptor as a new target for cancer therapy and chemoprotection. Fishman P, Bar-Yehuda S, Barer F, Madi L, Multani AS, Pathak S. Exp Cell Res; 2001 Oct 01; 269(2):230-6. PubMed ID: 11570815 [Abstract] [Full Text] [Related]
28. Leridistim, a chimeric dual G-CSF and IL-3 receptor agonist, enhances multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression: effect of schedule, dose, and route of administration. Farese AM, Casey DB, Smith WG, Vigneulle RM, McKearn JP, MacVittie TJ. Stem Cells; 2001 Jul 01; 19(6):522-33. PubMed ID: 11713344 [Abstract] [Full Text] [Related]
30. The synergistic effect of thrombopoietin in erythropoiesis with erythropoietin and/or IL-3 and myelopoiesis with G-CSF or IL-3 from umbilical cord blood cells of full-term neonates. Liang DC, Shih LY, Kuo MC, Chai IJ, Su TH, Chen SH, Liu HC, Shimosaka A. Pediatr Hematol Oncol; 2001 Sep 01; 18(6):383-91. PubMed ID: 11554233 [Abstract] [Full Text] [Related]
32. [Mobilization of autologous peripheral blood stem cells by chemotherapy and recombinant granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF)]. Cui X, Shao Y, Ren B, Tong Z, Ren X, Li L, Zhang Z, Zhang N, Dai R, Hao X. Zhonghua Xue Ye Xue Za Zhi; 2000 May 01; 21(5):247-9. PubMed ID: 11876989 [Abstract] [Full Text] [Related]
33. Granulocyte colony-stimulating factor and stem cell factor improve endogenous repair after myocardial infarction. Kanellakis P, Slater NJ, Du XJ, Bobik A, Curtis DJ. Cardiovasc Res; 2006 Apr 01; 70(1):117-25. PubMed ID: 16497284 [Abstract] [Full Text] [Related]
34. Granulocyte colony-stimulating factor promotes tumor angiogenesis via increasing circulating endothelial progenitor cells and Gr1+CD11b+ cells in cancer animal models. Okazaki T, Ebihara S, Asada M, Kanda A, Sasaki H, Yamaya M. Int Immunol; 2006 Jan 01; 18(1):1-9. PubMed ID: 16352631 [Abstract] [Full Text] [Related]
35. Activation of Nrf2-ARE signaling mitigates cyclophosphamide-induced myelosuppression. Que L, He L, Yu C, Yin W, Ma L, Cao B, Yu S. Toxicol Lett; 2016 Nov 16; 262():17-26. PubMed ID: 27633142 [Abstract] [Full Text] [Related]
36. Granulocyte colony-stimulating factor and its receptor in normal hematopoietic cell development and myeloid disease. van de Geijn GJ, Aarts LH, Erkeland SJ, Prasher JM, Touw IP. Rev Physiol Biochem Pharmacol; 2003 Nov 16; 149():53-71. PubMed ID: 12687405 [Abstract] [Full Text] [Related]
38. Increased bone marrow production of granulocytes and mononuclear phagocytes induced by mycobacterial adjuvants: improved recovery of leukopoiesis in mice after cyclophosphamide treatment. Buhles WC, Shifrine M. Infect Immun; 1978 Apr 16; 20(1):58-65. PubMed ID: 352938 [Abstract] [Full Text] [Related]